Literature DB >> 30714987

Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.

Parisa Malekzadeh1, Anna Pasetto1, Paul F Robbins1, Maria R Parkhurst1, Biman C Paria1, Li Jia1, Jared J Gartner1, Victoria Hill1, Zhiya Yu1, Nicholas P Restifo1, Abraham Sachs1, Eric Tran1,2, Winifred Lo1, Robert Pt Somerville1, Steven A Rosenberg1, Drew C Deniger1.   

Abstract

Entities:  

Keywords:  Cancer; Immunology; Oncology; P53; T cells

Mesh：

Substances：

Year:  2019        PMID： 30714987      PMCID： PMC6391139          DOI： 10.1172/JCI123791

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  20 in total

1.  Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.

Authors:  Sanja Stevanović; Anna Pasetto; Sarah R Helman; Jared J Gartner; Todd D Prickett; Bryan Howie; Harlan S Robins; Paul F Robbins; Christopher A Klebanoff; Steven A Rosenberg; Christian S Hinrichs
Journal:  Science       Date:  2017-04-14       Impact factor: 47.728

2.  Immunogenicity of somatic mutations in human gastrointestinal cancers.

Authors:  Eric Tran; Mojgan Ahmadzadeh; Yong-Chen Lu; Alena Gros; Simon Turcotte; Paul F Robbins; Jared J Gartner; Zhili Zheng; Yong F Li; Satyajit Ray; John R Wunderlich; Robert P Somerville; Steven A Rosenberg
Journal:  Science       Date:  2015-10-29       Impact factor: 47.728

3.  Comprehensive Characterization of Cancer Driver Genes and Mutations.

Authors:  Matthew H Bailey; Collin Tokheim; Eduard Porta-Pardo; Sohini Sengupta; Denis Bertrand; Amila Weerasinghe; Antonio Colaprico; Michael C Wendl; Jaegil Kim; Brendan Reardon; Patrick Kwok-Shing Ng; Kang Jin Jeong; Song Cao; Zixing Wang; Jianjiong Gao; Qingsong Gao; Fang Wang; Eric Minwei Liu; Loris Mularoni; Carlota Rubio-Perez; Niranjan Nagarajan; Isidro Cortés-Ciriano; Daniel Cui Zhou; Wen-Wei Liang; Julian M Hess; Venkata D Yellapantula; David Tamborero; Abel Gonzalez-Perez; Chayaporn Suphavilai; Jia Yu Ko; Ekta Khurana; Peter J Park; Eliezer M Van Allen; Han Liang; Michael S Lawrence; Adam Godzik; Nuria Lopez-Bigas; Josh Stuart; David Wheeler; Gad Getz; Ken Chen; Alexander J Lazar; Gordon B Mills; Rachel Karchin; Li Ding
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

Review 4.  Why are there hotspot mutations in the TP53 gene in human cancers?

Authors:  Evan H Baugh; Hua Ke; Arnold J Levine; Richard A Bonneau; Chang S Chan
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

5.  Immunological characterization of missense mutations occurring within cytotoxic T cell-defined p53 epitopes in HLA-A*0201+ squamous cell carcinomas of the head and neck.

Authors:  Daisuke Ito; Carmen Visus; Thomas K Hoffmann; Vera Balz; Henning Bier; Ettore Appella; Theresa L Whiteside; Robert L Ferris; Albert B DeLeo
Journal:  Int J Cancer       Date:  2007-06-15       Impact factor: 7.396

6.  Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells.

Authors:  Marc R Theoret; Cyrille J Cohen; Azam V Nahvi; Lien T Ngo; Kimberly B Suri; Daniel J Powell; Mark E Dudley; Richard A Morgan; Steven A Rosenberg
Journal:  Hum Gene Ther       Date:  2008-11       Impact factor: 5.695

7.  Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System.

Authors:  Drew C Deniger; Anna Pasetto; Eric Tran; Maria R Parkhurst; Cyrille J Cohen; Paul F Robbins; Laurence Jn Cooper; Steven A Rosenberg
Journal:  Mol Ther       Date:  2016-03-05       Impact factor: 11.454

8.  Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer.

Authors:  Nikolaos Zacharakis; Harshini Chinnasamy; Mary Black; Hui Xu; Yong-Chen Lu; Zhili Zheng; Anna Pasetto; Michelle Langhan; Thomas Shelton; Todd Prickett; Jared Gartner; Li Jia; Katarzyna Trebska-McGowan; Robert P Somerville; Paul F Robbins; Steven A Rosenberg; Stephanie L Goff; Steven A Feldman
Journal:  Nat Med       Date:  2018-06-04       Impact factor: 53.440

9.  A mouse mutant p53 product recognized by CD4+ and CD8+ T cells.

Authors:  Y Noguchi; Y T Chen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

Review 10.  Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies.

Authors:  R Vermeij; N Leffers; S H van der Burg; C J Melief; T Daemen; H W Nijman
Journal:  J Biomed Biotechnol       Date:  2011-03-15
View more
  82 in total

1.  SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.

Authors:  Siwen Hu-Lieskovan; Srabani Bhaumik; Kavita Dhodapkar; Jean-Charles J B Grivel; Sumati Gupta; Brent A Hanks; Sylvia Janetzki; Thomas O Kleen; Yoshinobu Koguchi; Amanda W Lund; Cristina Maccalli; Yolanda D Mahnke; Ruslan D Novosiadly; Senthamil R Selvan; Tasha Sims; Yingdong Zhao; Holden T Maecker
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

2.  Cancer neoantigens targeted by adoptive T cell transfer: private no more.

Authors:  Enrico Lugli; Pia Kvistborg; Giovanni Galletti
Journal:  J Clin Invest       Date:  2019-02-04       Impact factor: 14.808

Review 3.  Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors.

Authors:  Vid Leko; Steven A Rosenberg
Journal:  Cancer Cell       Date:  2020-08-20       Impact factor: 31.743

4.  Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic.

Authors:  Laura T Morton; Rogier M Reijmers; Anne K Wouters; Christiaan Kweekel; Dennis F G Remst; Cilia R Pothast; J H Frederik Falkenburg; Mirjam H M Heemskerk
Journal:  Mol Ther       Date:  2019-10-04       Impact factor: 11.454

5.  Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.

Authors:  Maria R Parkhurst; Paul F Robbins; Eric Tran; Todd D Prickett; Jared J Gartner; Li Jia; Gabriel Ivey; Yong F Li; Mona El-Gamil; Almin Lalani; Jessica S Crystal; Abraham Sachs; Eric Groh; Satyajit Ray; Lien T Ngo; Scott Kivitz; Anna Pasetto; Rami Yossef; Frank J Lowery; Stephanie L Goff; Winifred Lo; Gal Cafri; Drew C Deniger; Parisa Malekzadeh; Mojgan Ahmadzadeh; John R Wunderlich; Robert P T Somerville; Steven A Rosenberg
Journal:  Cancer Discov       Date:  2019-06-04       Impact factor: 39.397

Review 6.  The p53 Saga: Early Steps in the Development of Tumor Immunotherapy.

Authors:  Albert B DeLeo; Ettore Appella
Journal:  J Immunol       Date:  2020-05-01       Impact factor: 5.422

7.  Impact of Cysteine Residues on MHC Binding Predictions and Recognition by Tumor-Reactive T Cells.

Authors:  Abraham Sachs; Eugene Moore; Zeynep Kosaloglu-Yalcin; Bjoern Peters; John Sidney; Steven A Rosenberg; Paul F Robbins; Alessandro Sette
Journal:  J Immunol       Date:  2020-06-22       Impact factor: 5.422

8.  Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens.

Authors:  Parisa Malekzadeh; Rami Yossef; Gal Cafri; Biman C Paria; Frank J Lowery; Mohammad Jafferji; Meghan L Good; Abraham Sachs; Amy R Copeland; Sanghyun P Kim; Scott Kivitz; Maria R Parkhurst; Paul F Robbins; Satyajit Ray; Liqiang Xi; Mark Raffeld; Zhiya Yu; Nicholas P Restifo; Robert P T Somerville; Steven A Rosenberg; Drew C Deniger
Journal:  Clin Cancer Res       Date:  2020-01-29       Impact factor: 12.531

9.  T cell epitope screening of Epstein-Barr virus fusion protein gB.

Authors:  Haiwen Chen; Xiao Zhang; Shanshan Zhang; Xiaobing Duan; Tong Xiang; Xiang Zhou; Wanlin Zhang; Xinyu Zhang; Qisheng Feng; Yinfeng Kang; Jiangping Li; Lan Deng; Liang Wang; Xing Lv; Musheng Zeng; Yi-Xin Zeng; Miao Xu
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

Review 10.  Developing neoantigen-targeted T cell-based treatments for solid tumors.

Authors:  Tori N Yamamoto; Rigel J Kishton; Nicholas P Restifo
Journal:  Nat Med       Date:  2019-10-07       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.